Publicaciones en las que colabora con MARÍA INMACULADA GARCÍA GARCÍA (30)

2007

  1. In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in spain: A comparative multicenter study (2002-2004)

    Journal of Chemotherapy, Vol. 19, Núm. 3, pp. 263-270

2006

  1. Molecular epidemiology of drug-resistant Salmonella Typhimurium in Spain

    Revista Espanola de Quimioterapia, Vol. 19, Núm. 2, pp. 152-160

  2. Salmonella enterica serovar Enteritidis producing a TEM-52 β-lactamase: first report in Spain

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 3, pp. 245-246

2005

  1. Salmonella enterica serovar infantis producing a CTX-M-9 β-lactamase [2]

    Antimicrobial Agents and Chemotherapy

2004

  1. Resistencia a antimicrobianos en Salmonella no typhi en Castilla y León

    Revista Espanola de Quimioterapia, Vol. 17, Núm. 1, pp. 29-36

1997

  1. In vitro activities of β-lactam-β-lactamase inhibitor combinations against Stenotrophomonas maltophilia: Correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 12, pp. 2612-2615

  2. MECANISMOS DE RESISTENCIA A COMBINACIONES DE BETALACTAMICO E INHIBIDOR DE BETALACTAMASAS EN ESCHERICHIA COLI

    Revista Espanola de Quimioterapia, Vol. 10, Núm. 3, pp. 221-225

1995

  1. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria

    Journal of Chemotherapy, Vol. 7, Núm. 3, pp. 189-196

  2. Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 5, pp. 456-459

1994

  1. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis

    Journal of Chemotherapy, Vol. 6, Núm. 2, pp. 102-106

  2. In vitro activity of fosfomycin trometamol against urinary tract pathogens

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 2, pp. 123-130

  3. L-627, a novel carbapenem: In-vitro activity against anaerobes

    Journal of Antimicrobial Chemotherapy

1993

  1. GLUCOPEPTIDOS: VANCOMICINA Y TEICOPLANINA

    Revista Espanola de Quimioterapia, Vol. 6, Núm. 4, pp. 275-282

1992

  1. Current status of bacterial resistance to third-generation cephalosporins

    Diagnostic Microbiology and Infectious Disease, Vol. 15, Núm. 1, pp. 67-72

1991

  1. Antibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinations

    Diagnostic Microbiology and Infectious Disease, Vol. 14, Núm. 3, pp. 239-243

  2. Case report

    Infectious Diseases Newsletter, Vol. 10, Núm. 1, pp. 6-7

  3. In vitro activity of six antacids and a urease inhibitor against Helicobacter pylori

    Revista Espanola de Quimioterapia

  4. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia

    Journal of Chemotherapy, Vol. 3, Núm. 3, pp. 143-146

  5. Luetic serology (RPR and FTA-ABS) in a general hospital: Over-use and false-positive reactions

    Revista Espanola de Microbiologia Clinica, Vol. 6, Núm. 1, pp. 16-19

  6. Rapid diagnosis of Xanthomonas maltophilia

    Revista Espanola de Quimioterapia, Vol. 4, Núm. 4, pp. 333-335